Stress-Induced Pathophysiology Within the Schizophrenia Patient Brain

Adolescent Psychopathology and the Developing Brain: Integrating Brain and Prevention Science

Volumn , Issue , 2007, Pages

  Grace, Anthony A ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Anti anxiety medications; Genetic risk; Psychosis; Stress

Indexed keywords

EID: 84918935019     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1093/acprof:oso/9780195306255.003.0011     Document Type: Chapter

References (72)

1. Abercrombie, E. D., & Jacobs, B. L. (1988). Systemic naloxone administration potentiates locus coeruleus noradrenergic neuronal activity under stressful but not non-stressful conditions. Brain Research, 441, 362-366.
2. Abercrombie, E. D., Keller, R. W., Jr., & Zigmond, M. J. (1988). Characterization of hip-pocampal norepinephrine release as measured by microdialysis perfusion: Pharmacological and behavioral studies. Neuroscience, 27, 897-904.
3. Abercrombie, E. D., Nisenbaum, L. K., & Zigmond, M. J. (1992). Impact of acute and chronic stress on the release and synthesis of norepinephrine in brain: microdialysis studies in behaving animals. In R. Kvetnansky, R. McCarty, & J. Axelrod (Eds.), Stress: Neuroendocrine and molecular approaches (pp. 29-42). New York: Gordon and Breach Science Publishers.
4. Akil, M., Pierri, J. N., Whitehead, R. E., Edgar, C. L., Mohila, C., Sampson, A. R., & Lewis, D. A. (1999). Lamina-specific alterations in the dopamine innervation of the prefrontal cortex in schizophrenic subjects. American Journal of Psychiatry, 156, 1580-1589.
5. An der Heiden, W., & Hafner, H. (2000). The epidemiology of onset and course of schizophrenia. European Archives of Psychiatry and Clinical Neuroscience, 250, 292-303.
6. Baare, W. F., van Oel, C. J., Hulshoff Pol, H. E., Schnack, H. G., Durston, S., Sitskoorn, M. M., & Kahn, R. S. (2001). Volumes of brain structures in twins discordant for schizophrenia. Archives of General Psychiatry, 58, 33-40.
7. Birley, J., & Brown, G. W. (1970). Crisis and life changes preceding the onset or relapse of acute schizophrenia: Clinical aspects. British Journal of Psychiatry, 16, 327-333.
8. Bunney, B. S., & Grace, A. A. (1978). Acute and chronic haloperidol treatment: Comparison of effects on nigral dopaminergic cell activity. Life Sciences, 23, 1715-1727.
9. Corcoran, C., Walker, E., Huot, R., Mittal, V., Tessner, K., Kestler, L., & Malaspina, D. (2003). The stress cascade and schizophrenia: Etiology and onset. Schizophrenia Bulletin, 29, 671-692.
10. Cornblatt, B. A., Lencz, T., & Kane, J. M. (2001). Treatment of the schizophrenia prodome: Is it presently ethical? Schizophrenia Research, 51, 331-338.
11. Cornblatt, B., Lencz, T., & Obuchowski, M. (2002). The schizophrenia prodrome: Treatment and high-risk perspectives. Schizophrenia Research, 54, 177-186.
12. Correll, C. M., Rosenkranz, J. A., & Grace, A.A. (2005). Chronic cold stress alters prefrontal cortical modulation of amygdala neuronal activity in rats. Biological Psychiatry, 58, 382-391.
13. Finlay, J. M., & Zigmond, M. J. (1997). The effects of stress on central dopaminergic neurons: Possible clinical implications. Neurochemical Research, 22, 1387-1394.
14. Finlay, J. M., Zigmond, M. J., & Abercrombie, E. D. (1995). Increased dopamine and norepinephrine release in medial prefrontal cortex induced by acute and chronic stress: Effects of diazepam. Neuroscience, 64, 619-628.
15. Goldman-Rakic, P. S. (1998). The cortical dopamine system: Role in memory and cognition. Advances in Pharmacology, 42, 707-711.
16. Grace, A. A. (1991). Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia. Neuroscience, 41, 1-24.
17. Grace, A. A. (2000). Gating of information flow within the limbic system and the patho-physiology of schizophrenia. Brain Research Reviews, 31, 330-341.
18. Grace, A. A. (2004). Developmental dysregulation of the dopamine system and the patho-physiology of schizophrenia. In M. S. Keshavan, J. L. Kennedy, & R. M. Murray (Eds.), Neurodevelopment and schizophrenia (pp. 273-294). Cambridge, UK: Cambridge University Press.
19. Grace, A. A., & Moore, H. (1998). Regulation of information flow in the nucleus accumbens: A model for the pathophysiology of schizophrenia. In M. F. Lenzenweger & R. H. Dworkin (Eds.), Origins and development of schizophrenia: Advances in experimental psychopathology (pp. 123-157)., Washington, DC: American Psychological Association Press.
20. Gray, T. S. (1999). Functional and anatomical relationships among the amygdala, basal forebrain, ventral striatum, and cortex: An integrative discussion. Annals of the New York Academy of Sciences, 877, 439-444.
21. Häfner, H., Maurer, K., Löffler, W., & Riecher-Rössler, A. (1993). The influence of age and sex on the onset and early course of schizophrenia. British Journal of Psychiatry, 162, 80-86.
22. Hariri, A. R., Mattay, V. S., Tessitore, A., Fera, F., and Weinberger, D. R. (2003). Neo-cortical modulation of the amygdala response to fearful stimuli. Biological Psychiatry, 53, 494-501.
23. Howes, O. D., McDonald, C., Cannon, M., Arseneault, L., Boydell, J., & Murray, R. M. (2004). Pathways to schizophrenia: The impact of environmental factors. International Journal of Neuropsychopharmacology, 7(Suppl. 1), S7-S13.
24. Jedema, H. P., & Grace, A. A. (2003a). Chronic exposure to cold stress alters electro-physiological properties of locus coeruleus neurons recorded in vitro. Neuropsychopharmacology, 28, 63-72.
25. Jedema, H. P., & Grace, A. A. (2003b). The effect of corticotropin-releasing hormone on noradrenergic neurons of the locus coeruleus recorded in vitro. Journal of Neuroscience, 24, 9703-9713.
26. Johnstone, E.C., Ebmeier, K.P., Miller, P., Owens, D.G., & Lawrie, S.M. (2005). Predicting schizophrenia: findings from the Edinburgh High-Risk Study. British Journal of Psychiatry, 186: 18-25.
27. Kapur, S. (2003). Psychosis as a state of aberrant salience: a framework linking biology, phenomenology, and pharmacology in schizophrenia. American Journal of Psychiatry, 160, 13-23.
28. Kendler, K. S., Gallagher, T. J., Abelson, J. M., & Kessler, R. C. (1996). Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis as assessed in a U.S. community sample: The National Comorbidity Survey. Archives of General Psychiatry, 53, 1022-1031.
29. Kendler, K. S., Tsuang, M. T., & Hays, P. (1987). Age at onset in schizophrenia: A familial perspective. Archives of General Psychiatry, 44, 881-890.
30. Kirkpatrick, B., Buchanan, R. W., Ross, D. E., & Carpenter, W. T., Jr. (2001). A separate disease within the syndrome of schizophrenia. Archives of General Psychiatry, 58, 165-171.
31. Kretteck, J. E., & Price, J. L. (1978). A description of the amygdaloid complex in the rat and cat with observations on intra-amygdaloid axonal connections. Journal of Comparative Neurology, 178, 255-280.
32. Kroner, S., Rosenkranz, J. A., Grace, A. A., & Barrionuevo, G. (2005). Dopamine modulates excitability of basolateral amygdala neurons in vitro. Journal of Neurophysiology, 93, 1598-1610.
33. Laruelle, M. (1998). Imaging dopamine transmission in schizophrenia. A review and meta-analysis. Quarterly Journal of Nuclear Medicine, 42, 211-221.
34. LeDoux, J. E. (2000). Emotion circuits in the brain. Annual Review of Neuroscience, 23, 155-184.
35. Lewis, D. A., Pierri, J. N., Volk, D. W., Melchitzky, D. S., & Woo, T. U. (1999). Altered GABA neurotransmission and prefrontal cortical dysfunction in schizophrenia. Biological Psychiatry, 46, 616-626.
36. Likhtik, E., Pelletier, J. G., Paz, R., & Paré, D. (2005). Prefrontal control of the amygdala. Journal of Neuroscience, 25, 7429-7437.
37. Lipska, B. K., Jaskiw, G. E., & Weinberger, D. R. (1993). Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippo-campal damage: A potential animal model of schizophrenia. Neuropsychopharma-cology, 9, 67-75.
38. Loranger, A. W. (1984). Sex difference in age at onset of schizophrenia. Archives of General Psychiatry, 41, 157-161.
39. Mana, M. J., & Grace, A. A. (1997). Chronic cold stress alters the basal and evoked elec-trophysiological activity of rat locus coeruleus neurons. Neuroscience, 81, 1055-1064.
40. Moore, H., Ghajarnia, M., Geyer, M., Jentsch, J. D., & Grace, A. A. (2001a). Selective disruption of prefrontal and limbic corticostriatal circuits by prenatal exposure to the DNA methylating agent methylazoxymethanol acetate: Anatomical, neurophysiologi-cal and behavioral studies. Schizophrenia Research, 49(Suppl.), 48.
41. Moore, H., Ghajarnia, M. E., Jentsch, J. D., Geyer, M. A., & Grace, A. A. (2006). A Neurobehavioral Systems Analysis of Adult Rats Exposed to Methylazoxymethanol Acetate on E17: Implications for the Neuropathology of Schizophrenia Biological Psychiatry, 60, 253-264.
42. Moore, H., Rose, H. J., & Grace, A. A. (2001b). Chronic cold stress reduces the spontaneous activity of ventral tegmental dopamine neurons. Neuropsychopharmacology, 24, 410-419.
43. Norman, R. M. G., & Malla, A. K. (1993). Stressful life events and schizophrenia. I: A review of research. British Journal of Psychiatry, 162, 161-166.
44. O'Donnell, P., & Grace, A. A. (1995). Synaptic interactions among excitatory afferents to nucleus accumbens neurons: Hippocampal gating of prefrontal cortical input. Journal of Neuroscience, 15, 3622-3639.
45. O'Donnell, P., & Grace, A. A. (1998b). Phencyclidine interferes with the hippocampal gating of nucleus accumbens neuronal activity in vivo. Neuroscience, 87, 823-830.
46. Pantelis, C., Velakoulis, D., Suckling, J., McGorry, P. D., Phillips, L., Yung, A., Wood, S., Bullmore, E., Brewer, W., Soulsby, B., & McGuire, P. (2000). Left medial temporal volume reduction occurs during the transition from high-risk to first-episode psychosis. Schizophrenia Research, 41, 35.
47. Parnas, J. (1999). From predisposition to psychosis: Progression of symptoms in schizophrenia. Acta Psychiatrica Scandinavica, Supplementum, 99, 20-29.
48. Parnas, J., & Jorgensen, A. (1989). Pre-morbid psychopathology in schizophrenia spectrum. British Journal of Psychiatry, 155, 623-627.
49. Parnas, J., Schulsinger, F., Schulsinger, H., Mednick, S. A., & Teasdale, T. W. (1982). Behavioral precursors of schizophrenia spectrum. Archives of General Psychiatry, 39, 658-664.
50. Pogue-Geile, M. F. (1997). Developmental aspects of schizophrenia. In M. S. Keshavan & R. M. Murray (Eds.), Neurodevelopment and adult psychopathology (pp. 137-154). New York, Cambridge University Press.
51. Quirk, G. J., Likhtik, E., Pelletier, J. G., & Pare, D. (2003). Stimulation of medial prefrontal cortex decreases the responsiveness of central amygdala output neurons. Journal of Neuroscience, 23, 8800-8807.
52. Ramsooksingh, M. D., Jedema, H.P., & Grace, A. A. (2004). Stimulation of the central nucleus of the amygdala increases single unit activity of locus coeruleus neurons. Society for Neurosciences Abstract, 29, Program No. 282.210.
53. Rosenkranz, J. A., Buffalari, D. M. & Grace, A. A. (2006). Opposing influence of basolateral amygdala and footshock stimulation on neurons of the central amygdala. Biological Psychiatry, 59: 801-811.
54. Rosenkranz, J. A., & Grace, A. A. (1999). Modulation of basolateral amygdala neuronal firing and afferent drive by dopamine receptor activation in vivo. Journal of Neuroscience, 19, 11027-11039.
55. Rosenkranz, J. A., & Grace, A. A. (2001). Dopamine attenuates prefrontal cortical suppression of sensory inputs to the basolateral amygdala of rats. Journal of Neuroscience, 21, 4090-4103.
56. Rosenkranz, J. A., & Grace, A. A. (2002a). Cellular mechanisms of infralimbic and prelimbic prefrontal cortical inhibition and dopaminergic modulation of basolateral amygdala neurons in vivo. Journal of Neuroscience, 22, 324-337.
57. Rosenkranz, J. A., & Grace, A. A. (2002b). Dopamine-mediated modulation of odour-evoked amygdala potentials during Pavlovian conditioning. Nature, 417, 282-287.
58. Rosenkranz, J. A., Moore, H., & Grace, A. A. (2003). The prefrontal cortex regulates lateral amygdala neuronal plasticity and responses to previously conditioned stimuli. Journal of Neuroscience, 23, 11054-11064.
59. Sapolsky, R. M. (1996). Stress, glucocorticoids, and damage to the nervous system: The current state of confusion. Stress, 1, 1-19.
60. Sapolsky, R. M. (1999). Glucocorticoids, stress, and their adverse neurological effects: Relevance to aging. Experimental Gerontology, 34, 721-732.
61. Sapolsky, R. M., Krey, L. C., & McEwen, B. S. (1985). Prolonged glucocorticoid exposure reduces hippocampal neuron number: Implications for aging. The Journal of Neuroscience, 5, 1222-1227.
62. Sapolsky, R. M., Uno, H., Rebert, C. S., & Finch, C. E. (1990). Hippocampal damage associated with prolonged glucocorticoid exposure in primates. Journal of Neuroscience, 10, 2897-2902.
63. Shanks, N., Zalcman, S., Zacharko, R. M., & Anisman, H. (1991). Alterations of central norepinephrine, dopamine and serotonin in several strains of mice following acute stres-sor exposure. Pharmacology, Biochemistry & Behavior, 38, 69-75.
64. Thierry, A. M., Javoy, F., Glowinski, J., & Kety, S. S. (1968). Effects of stress on the metabolism of norepinephrine, dopamine and serotonin in the central nervous system of the rat. I. Modifications of norepinephrine turnover. Journal of Pharmacology & Experimental Therapeutics, 163, 163-171.
65. Thompson, J. L., Pogue-Geile, M. F., & Grace, A. A. (2004). The interactions among developmental pathology, dopamine, and stress as a model for the age of onset of schizophrenia symptomatology. Schizophrenia Bulletin, 30, 875-900.
66. Valentino, R. J., & Foote, S. L. (1986). Brain noradrenergic neurons, corticotropin-releasing factor, and stress. In T. W. Moody (Ed.), Neural and endocrine peptides and receptors (pp. 101-120). New York: Plenum Press.
67. Valentino, R. J., & Foote, S. L. (1988). Corticotropin-releasing hormone increases tonic but not sensory-evoked activity of noradrenergic locus coeruleus neurons in unanes-thetized rats. Journal of Neuroscience, 8, 1016-1025.
68. Veening, J. G., Swanson, L. W., & Sawchenko, P. E. (1984). The organization of projections from the central nucleus of the amygdala to brainstem sites involved in central autonomic regulation: A combined retrograde transportimmunohistochemical study. Brain Research 303(2), 337-357.
69. Walker, E. F., & Diforio, D. (1997). Schizophrenia: A neural diathesis-stress model. Psychological Review, 104, 667-685.
70. Weinberger, D. R., Zigun, J. R., Bartley, A. J., Jones, D. W., & Torrey, E. F. (1992). Anatomical abnormalities in the brains of monozygotic twins discordant and concordant for schizophrenia. Clinical Neuropharmacology, 15, 122A-123A.
71. Yang, C. R., & Seamans, J. K. (1996). Dopamine D1 receptor actions in layers V-VI rat prefrontal cortex neurons in vitro: Modulation of dendriticsomatic signal integration. Journal of Neuroscience, 16, 1922-1935.
72. Zigmond, M. J., Finlay, J. M., & Sved, A. F. (1995). Neurochemical studies of central noradrenergic responses to acute and chronic stress. In M. J. Friedman, D. S. Charney, & A. Y. Deutsch (Eds.), Neurobiological and clinical consequences of stress: From normal adaptation to PTSD (pp. 45-60). Philadelpia: Lippincott-Raven.